|
Course Information
|
Back to Catalog
|
This lesson is supported by:
|
by Joseph A. Kanapka, Ph.D., Stephen Vanner, M.Sc., M.D., FRCPC, David H. Balaban, M.D.
Dr. Kanapka is the Director of Product Safety at C. B. Fleet Pharmaceuticals in Lynchburg VA and presented Appropriate Use of Oral Sodium Phosphate Liquid - Dosing and Electrolyte Changes
Dr. Vanner is in the GI Diseases Research Unit at Queen's University in Kingston, Ontario, Canada and presented Review of the Safety of Oral Sodium Phosphate Preps
Dr. Balaban is from Charlottesville Gastroenterology Associates, Charlottesville Medical Research in Charlottesville, VA and presented Multicenter Trial of Oral Sodium Phosphate Liquid vs. Two Dosing Regimens of Oral Sodium Phosphate Tablets
Faculty Disclosure
Dr. Kanapka made the following disclosure: I am the Director of Product Safety at C. B. Fleet Pharmaceuticals.
Dr. Vanner made the following disclosure: I am currently receiving unrestricted grants from CB Fleet CO. to support clinical studies examining safety issues related to oral sodium phosphate to colon cleansing. Additionally I have received speaker honorarium from C.B. Fleet CO for presentations related to safety issues relating to oral sodium phosphate for colon cleansing.
Dr. Balaban made the following disclosure: I am a paid consultant to C.B. Fleet CO and serve on its speakers bureau.
Goals and Objectives
Learning Objectives
- Describe the cause and effect of electrolyte shifts associated with oral sodium phosphate (NaP) bowel cleansers.
- Discuss proper patient selection and dosing of NaP.
- Explain safety measures to be taken when patients are preparing for colonoscopy.
|
|
|
|
|
|
|
Technologies Used
|
|
|
 Macromedia Flash
 Streaming Media
|
|
|
|
Price: FREE!
|
|
ACPE Accreditation
|
|
RxSchool is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This home study web activity has been assigned a maximum of 1.5 credit hours (0.15 CEU) and the ACPE UPN: 372-000-04-011-H01.
Expiration Date: 01/02/2008
Release Date: 01/02/2005
|
| |
To receive educational credit, participants must complete an online evaluation form and pass the online assessment with a score of 70% or better. If you do not receive a minimum score of 70% or better, you are permitted 1 retake(s). After passing the assessment, you can view, print and track your statements of credit online. There is no fee to participate in this activity.
|
|
|
The material presented here does not reflect the views of Pharmacy Choice, Inc., RxSchool, or the companies providing educational content. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.
|
This lesson is supported by:
|
|
|
